北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学首钢医院  > 期刊论文
学科主题: 临床医学
题名:
Long-term risk of late and very late stent thrombosis in patients treated with everolimus against paclitaxel-eluting stents: an updated meta-analysis
作者: Li, Peng1; Liu, Jun-Peng2
关键词: diabetes ; everolimus-eluting stent ; major adverse cardiac event ; paclitaxel-eluting stent ; very late stent thrombosis
刊名: CORONARY ARTERY DISEASE
发表日期: 2014-08-01
DOI: 10.1097/MCA.0000000000000109
卷: 25, 期:5, 页:369-377
收录类别: SCI
文章类型: Article
WOS标题词: Science & Technology
类目[WOS]: Peripheral Vascular Disease
研究领域[WOS]: Cardiovascular System & Cardiology
关键词[WOS]: CORONARY-ARTERY-DISEASE ; COMPREHENSIVE NETWORK METAANALYSIS ; BARE-METAL STENTS ; XIENCE V ; FOLLOW-UP ; CLINICAL-EVALUATION ; TRIAL ; OUTCOMES ; INTERVENTION ; SYSTEM
英文摘要:

Objectives Everolimus-eluting stent (EES) reduces the risk of late and very late stent thrombosis (ST) in a number of randomized controlled trials (RCTs). However, the benefits have been variable.

Materials and methods We evaluated the effect of EES and paclitaxel-eluting stent (PES) on the risk of late and very late ST in patients with coronary artery disease.

Results We identified RCTs by a systematic search of MEDLINE, EMBASE, and Cochrane Database. Seven RCTs (8162 patients) were included. Overall, EES therapy lowered the risk of very late ST significantly [relative risk (RR), 0.40; 95% confidence interval (CI), 0.20-0.80; I-2 = 0.0%; P = 0.009] compared with PES. Meanwhile, EES was associated with a significantly lower incidence of major adverse cardiac events (RR, 0.76; 95% CI, 0.67-0.86; I-2 = 34.2%; P = 0.00) driven by a markedly lower rate of myocardial infarction and target-vessel revascularization in the EES group. However, there was no significant difference in the risk of late ST (RR, 0.45; 95% CI, 0.15-1.39; I-2 = 30.7%; P = 0.166) between the two groups. A subgroup analysis showed that EES might not decrease the risk of very late ST significantly in patients older than 63.5 years or in patients with diabetes, those presenting with acute coronary syndrome, or those with a longer follow-up.

Conclusion Compared with PES, EES treatment decreased risk of very late ST significantly. However, the risk of late ST was similar between the two groups. More studies are needed to confirm the subgroup findings. (C) 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins.

语种: 英语
WOS记录号: WOS:000339652100003
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/65036
Appears in Collections:北京大学首钢医院_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 1.Beijing Hosp, Dept Cardiol, Beijing 100730, Peoples R China
2.Peking Univ, Shougang Hosp, Dept ICU, Beijing 100871, Peoples R China

Recommended Citation:
Li, Peng,Liu, Jun-Peng. Long-term risk of late and very late stent thrombosis in patients treated with everolimus against paclitaxel-eluting stents: an updated meta-analysis[J]. CORONARY ARTERY DISEASE,2014,25(5):369-377.
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Li, Peng]'s Articles
[Liu, Jun-Peng]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Li, Peng]‘s Articles
[Liu, Jun-Peng]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit
所有评论 (0)
暂无评论
 
评注功能仅针对注册用户开放,请您登录
您对该条目有什么异议,请填写以下表单,管理员会尽快联系您。
内 容:
Email:  *
单位:
验证码:   刷新
您在IR的使用过程中有什么好的想法或者建议可以反馈给我们。
标 题:
 *
内 容:
Email:  *
验证码:   刷新

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace